INS and breast carcinoma: The insulin/insulin receptor (IR) signaling pathway plays an important role in breast cancer progression by stimulating the RAS/RAF/MAPK kinase/ERK cascade in breast tissues, which results in tumor cell proliferation, survival and migration [20, 21].